Tau profiling across Alzheimer's disease staging reveals vulnerability to disease pathophysiology

Eur J Nucl Med Mol Imaging. 2025 Sep;52(11):4281-4291. doi: 10.1007/s00259-025-07257-4. Epub 2025 Apr 25.

Abstract

Background: Inter-individual variability in tau topography challenges the propagation hypothesis of tau aggregates.

Methods: To address this gap, we propose the Manifold Component Analysis (MCA), for identifying pseudo-continuous profiles informed by the spatial continuity of stage regions.

Results: Longitudinal and cross-sectional MCA in large aging cohort identified individual profiles (N = 753) expressing tau load in the entorhinal, limbic and neocortical regions. Using these profiles, we found neuropsychological and blood-based milestones of early and late disease stages. Finally, we also found evidence of rapid tau load increases and cognitive decline centered at the early-to-mid neocortical stages of Alzheimer's disease.

Conclusions: Stage system based on tau load and spreading profiles across cortical areas provide a compelling framework for inferring pathophysiological prognosis in Alzheimer's disease.

Keywords: 18F-MK6240 PET; Alzheimer’s disease; Component analysis; Dimensionality reduction; Neurofibrillary tangles; PET braak staging; Propagation; Tau.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Alzheimer Disease* / physiopathology
  • Female
  • Humans
  • Male
  • Positron-Emission Tomography
  • tau Proteins* / metabolism

Substances

  • tau Proteins

Grants and funding